Bilateral Macular Retinitis as the Presenting Feature of Subacute Sclerosing Panencephalitis
Department of Uveitis, Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.Journal of Neuro-Ophthalmology (Impact Factor: 1.95). 01/2008; 27(4):288-91. DOI: 10.1097/WNO.0b013e31815b98e6
Two patients presented with retinitis as the initial clinical manifestation of subacute sclerosing panencephalitis (SSPE), a delayed neurologic complication of measles. In one patient, the ocular involvement preceded the neurologic symptoms by 4 weeks and in the other patient by 4 years. The diagnosis of SSPE was suspected when neuropsychiatric manifestations appeared and was confirmed by the typical panencephalitic electroencephalography changes, neuroimaging features of panencephalitis, and high titers of measles antibodies in serum and cerebrospinal fluid. Although SSPE is an untreatable illness, recognition of this unusual presentation is valuable to allow earlier diagnosis and institution of palliative measures.
- Journal of Pediatric Ophthalmology & Strabismus 07/2011; 48(4):255. DOI:10.3928/01913913-20110623-01 · 0.75 Impact Factor
Article: Challenges in diagnosing SSPE[Show abstract] [Hide abstract]
ABSTRACT: The typical clinical presentation of subacute sclerosing panencephalitis (SSPE) includes behavioral and intellectual changes followed by myoclonia. However, there are a considerable number of SSPE cases which present with distinct clinical features that can lead to a diagnostic difficulty. In this report, we summarize the clinical features of patients with SSPE who have uncommon presentations or features of the disease or coexisting medical conditions which may lead to diagnostic difficulties. We studied 173 patients, all under the age of 17. Patients were included in the study group according to following criteria: onset of the disease before age 2 years, seizures occurring before the onset of myoclonia and/or behavioral symptoms, extrapyramidal or cerebellar signs and ocular manifestations as initial presenting symptoms, fulminant course including coma or death within 6 months. Additionally, patients with onset of SSPE at the setting of a known neurological disorder are defined as another group in the study. Out of 173 patients with SSPE who were followed in two neurology centers, 31 (17.9%) met our criteria. We found a relative high frequency of these clinical features. Our findings suggest that clinicians should be aware of this clinical characteristics and rule out the disease in cases were other common causes have been excluded, especially in countries with insufficient measles immunization.Child s Nervous System 12/2011; 27(12):2041-4. DOI:10.1007/s00381-011-1603-x · 1.11 Impact Factor
- Canadian Journal of Ophthalmology 04/2012; 47(2):e1-2. DOI:10.1016/j.jcjo.2012.01.023 · 1.33 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.